This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 6.2% to $6.04 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.1% to 16,724.46 and the Dow Jones Industrial Average rising 1.6% to 40,212.71.
This was the stock's sixth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 90.2% below its 52-week high of $61.90, which the company reached on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.2% to $4.13, Fortress Biotech Inc. rose 3.5% to $1.46, and Viking Therapeutics Inc. rose 3.25% to $22.22.
Trading volume totaled 221,757, compared to the 50-day average of 250,078.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 11, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.